Evidence map›Paper›PMID 24789761›Full record

ReviewWiley interdisciplinary reviews. RNA

The role of SON in splicing, development, and disease.

Xinyi Lu, Huck-Hui Ng, Paula A Bubulya

Open access · greenAbstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. RNA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Resolving ScRNA-Seq Signatures of Antigen-Specific CD4bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. SON-dependent nuclear speckle rehabilitation alleviates proteinopathies.bioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. SON is an essential mCell stem cell · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Reading, writing and erasing mRNA methylation.Nature reviews. Molecular cell biology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Xinyi LuGene Regulation Laboratory, Genome Institute of Singapore, Singapore, Singapore.
Huck-Hui Ng
Paula A Bubulya
Genome Institute of Singapore · SGNanyang Technological University · SGWright State University · US

Funding

Pre-mRNA Processing Factors Maintain Normal MitosisR15GM084407 · NIGMS · WRIGHT STATE UNIVERSITY · PI BUBULYA, PAULA A. · 2009 to 2019
$1.3M
NIGMS NIH HHS GM084407-02NIGMS NIH HHS R15 GM084407
6 · The paper itself

Abstract

SON is a nuclear protein involved in multiple cellular processes including transcription, pre-messenger RNA (mRNA) splicing, and cell cycle regulation. Although SON was discovered 25 years ago, the importance of SON's function was only realized recently when its roles in nuclear organization and pre-mRNA splicing as well as the influence of these activities in maintaining cellular health were unveiled. Furthermore, SON was implicated to have a key role in stem cells as well as during the onset of various diseases such as cancer, influenza, and hepatitis. Here we review the progress that has been made in studying this multifunctional protein and discuss questions that remain to be answered about SON.

Indexed as

AnimalsCell CycleCell DifferentiationDNA-Binding ProteinsEmbryonic Stem CellsHematopoietic Stem CellsHepatitis BHumansMiceMinor Histocompatibility AntigensNeoplasmsRNA, MessengerRNA PrecursorsRNA SplicingDNA-Binding ProteinsMinor Histocompatibility AntigensRNA, MessengerRNA PrecursorsSON protein, human

Identifiers

PMID24789761
PMCPMC4138235
OpenAlexW1540451669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.